
At present, special efforts are being made to develop the strategies allowing for activation of long-lasting antigen-specific immune tolerance in therapy of allergic and autoimmune diseases. Some of these therapeutic approaches are aimed at modulating cell functions at genetic level by using miRNA-based and miRNA-targeting treatments. Simultaneously, the crucial role of extracellular vesicles as natural miRNA conveyors is highlighted for induction of antigen-specific immune tolerance, especially that they appear to be easily manipulatable for therapeutic applications. Among other immune-related miRNAs, miR-150 is getting special attention as it is differently expressed by immune cells at various stages of their maturation and differentiation. In addition, miR-150 is involved in different signaling cascades orchestrating humoral and cell-mediated mechanisms of both innate and adaptive immune responses. Therefore, miR-150 is considered a master regulator of immunity in mammals. Currently, physiological miR-150-dependent regulatory circuits and causes of their malfunctioning that underlie the pathogenesis of allergic and autoimmune disorders are being unraveled. Thus, present review summarizes the current knowledge of the role of miR-150 in the pathogenesis and complications of these diseases. Furthermore, the involvement of miR-150 in regulation of immune responses to allergens and self-antigens and in induction of antigen-specific immune tolerance is discussed with the special emphasis on the therapeutic potential of this miRNA.
Citation: Katarzyna Nazimek. The complex functions of microRNA-150 in allergy, autoimmunity and immune tolerance[J]. AIMS Allergy and Immunology, 2021, 5(4): 195-221. doi: 10.3934/Allergy.2021016
[1] | Rui Ma, Jinjin Han, Li Ding . Finite-time trajectory tracking control of quadrotor UAV via adaptive RBF neural network with lumped uncertainties. Mathematical Biosciences and Engineering, 2023, 20(2): 1841-1855. doi: 10.3934/mbe.2023084 |
[2] | Bin Hang, Beibei Su, Weiwei Deng . Adaptive sliding mode fault-tolerant attitude control for flexible satellites based on T-S fuzzy disturbance modeling. Mathematical Biosciences and Engineering, 2023, 20(7): 12700-12717. doi: 10.3934/mbe.2023566 |
[3] | Jian Meng, Bin Zhang, Tengda Wei, Xinyi He, Xiaodi Li . Robust finite-time stability of nonlinear systems involving hybrid impulses with application to sliding-mode control. Mathematical Biosciences and Engineering, 2023, 20(2): 4198-4218. doi: 10.3934/mbe.2023196 |
[4] | Yun Liu, Yuhong Huo . Predefined-time sliding mode control of chaotic systems based on disturbance observer. Mathematical Biosciences and Engineering, 2024, 21(4): 5032-5046. doi: 10.3934/mbe.2024222 |
[5] | Yuhang Yao, Jiaxin Yuan, Tao Chen, Xiaole Yang, Hui Yang . Distributed convex optimization of bipartite containment control for high-order nonlinear uncertain multi-agent systems with state constraints. Mathematical Biosciences and Engineering, 2023, 20(9): 17296-17323. doi: 10.3934/mbe.2023770 |
[6] | Xinggui Zhao, Bo Meng, Zhen Wang . Event-triggered integral sliding mode control for uncertain networked linear control systems with quantization. Mathematical Biosciences and Engineering, 2023, 20(9): 16705-16724. doi: 10.3934/mbe.2023744 |
[7] | Dongxiang Gao, Yujun Zhang, Libing Wu, Sihan Liu . Fixed-time command filtered output feedback control for twin-roll inclined casting system with prescribed performance. Mathematical Biosciences and Engineering, 2024, 21(2): 2282-2301. doi: 10.3934/mbe.2024100 |
[8] | Kangsen Huang, Zimin Wang . Research on robust fuzzy logic sliding mode control of Two-DOF intelligent underwater manipulators. Mathematical Biosciences and Engineering, 2023, 20(9): 16279-16303. doi: 10.3934/mbe.2023727 |
[9] | Ying Shi, Keqi Mei . Adaptive nonsingular terminal sliding mode controller for PMSM drive system using modified extended state observer. Mathematical Biosciences and Engineering, 2023, 20(10): 18774-18791. doi: 10.3934/mbe.2023832 |
[10] | Xinyu Shao, Zhen Liu, Baoping Jiang . Sliding-mode controller synthesis of robotic manipulator based on a new modified reaching law. Mathematical Biosciences and Engineering, 2022, 19(6): 6362-6378. doi: 10.3934/mbe.2022298 |
At present, special efforts are being made to develop the strategies allowing for activation of long-lasting antigen-specific immune tolerance in therapy of allergic and autoimmune diseases. Some of these therapeutic approaches are aimed at modulating cell functions at genetic level by using miRNA-based and miRNA-targeting treatments. Simultaneously, the crucial role of extracellular vesicles as natural miRNA conveyors is highlighted for induction of antigen-specific immune tolerance, especially that they appear to be easily manipulatable for therapeutic applications. Among other immune-related miRNAs, miR-150 is getting special attention as it is differently expressed by immune cells at various stages of their maturation and differentiation. In addition, miR-150 is involved in different signaling cascades orchestrating humoral and cell-mediated mechanisms of both innate and adaptive immune responses. Therefore, miR-150 is considered a master regulator of immunity in mammals. Currently, physiological miR-150-dependent regulatory circuits and causes of their malfunctioning that underlie the pathogenesis of allergic and autoimmune disorders are being unraveled. Thus, present review summarizes the current knowledge of the role of miR-150 in the pathogenesis and complications of these diseases. Furthermore, the involvement of miR-150 in regulation of immune responses to allergens and self-antigens and in induction of antigen-specific immune tolerance is discussed with the special emphasis on the therapeutic potential of this miRNA.
Quadrotors have been widely used in military, photography, navigation and other application fields due to their properties of economy, portability and flexibility. Comparing with helicopter or airplane, quadrotors are with simpler structure, so they are more available for engineering [1]. However, quadrotors are under-actuated systems, and how to design appropriate controllers for them have been attracting substantial attention.
Sliding mode control (SMC) is a nonlinear robust control method, which is considered to be one of the effective methods against uncertainties and disturbances [2]. In [3], the principle of sliding mode control was introduced and specific control strategies were designed for a class of underactuated systems. In [4], comparisons were made between SMC and feedback linearization method, the results indicated SMC was more robust for noises and disturbances. In [5], the authors divided a quadrotor into fully actuated and underactuated subsystems, and second order SMC was employed for the design of the underactuated subsystems, whose coefficients were obtained by Hurwitz stability. In [6,7], terminal sliding mode control (TSMC) was designed for quadrotors, with which faster convergence of trajectory tracking was achieved. In [8], sliding mode observers were used to estimate all states of the quadrotor through the measurable attitude and position of the quadrotor, and PID SMC was employed to guarantee the convergence of the trajectory tracking. An integrated sliding mode control (ISMC) was proposed in [9], which divided the quadrotor model into inner and outer loops. The outer loop mainly generated reference signals for the roll and pitch angles, and the inner loop achieved the position and attitude tracking with ISMC. In [10], model-free TSMC was designed, where the model-free method guaranteed that the tracking error of the quadrotor was bounded, while the terminal sliding mode guaranteed the convergence of the error. In [11], adaptive SMC was proposed to realize finite-time stability of a quadrotor through self-tuning. In [12], a super twisting control algorithm was proposed to enforce the sliding mode of the attitude of a quadrotor on the desired manifold, therefore, the robustness of the attitude tracking was guaranteed. In order to realize the tracking of uncertain dynamical systems, an adaptive nonsingular fast terminal sliding-mode control (ANFTSMC) algorithm was proposed in [13]. In [14], the ANFTSMC was applied to a quadrotor which was subject to modeling uncertainties and unknown external disturbances. In [15], disturbance observer based adaptive SMC was applied to a quadrotor subjected to parametric uncertainties and external disturbances, the effectiveness of the control was tested by numerical simulations and experiments. In [16], the authors presented an adaptive dynamic surface SMC for a quadrotor, they used nonlinear observer to estimate the states of the quadrotor, and used minimum learning technology to reduce computational burden, the controller was designed to ensure all signals of the system were uniformly ultimately bounded. In [17], the position loop was controlled by backstepping method, and the attitude loop was controlled by the fast TSMC, both of these methods were combined with adaptive technology to estimate the controller parameters, and upper bounds of the uncertainties and disturbances.
Neural network has been developed rapidly in recent years, and it has been introduced into the control of quadrotors to deal with nonlinearities and uncertainties. The authors of [18] combined neural networks with SMC, by adjusting the parameters of the sliding surface with back propagation algorithm, the overshoot of the system response and the steady state error were effectively reduced. A PID neural network control strategy was proposed in [19], where proportional, integral, and differential neurons were defined to construct a network, by which control inputs were designed to achieve quicker response of a quadrotor. Adaptive radial basis function neural networks (RBFNNs) were employed in [20] for the control of a quadrotor. In [21], RBFNN was used to generate the control signals of a quadrotor, by which the characteristic roots of the quadrotor system located in the left half plane, so the stability of the system was guaranteed. Backstepping design was combined with neural network in [22] to realize the control of a quadrotor with unknown input saturation. In [23] a learning-based scheme with neural networks was used to obtain the optimal control law for a quadrotor with time-varying and coupling uncertainties, the stability of the closed-loop system was proved by theory. The authors of [24] proposed RBFNNs based proportional derivative-sliding mode control (RPD-SMC) for the outer loop for position tracking, and employed the robust integral of the signum of error (RISE) to guarantee attitude convergence.
Optimization algorithms have been gradually employed to improve the performance of neural networks. Particle swarm optimization (PSO) algorithm base RBF network was designed in [25] to get better PID parameters. The authors of [26] used genetic algorithms to optimize RBFNNs for more accuracy modeling. In [27], genetic algorithm was also used for optimizing the hyperparameters of a two hidden layer neural network, by which the training and running time of the neural network was reduced. However, using the optimized neural networks in SMC to realize robust control of quadrotors has been rarely considered so far.
This paper aims to improve robust tracking performance of a quadrotor with unknown disturbances. SMC is employed to design the position and attitude control laws in the inner and outer loops, RBFNNs are introduced to approximate the unknown parts of the control laws. The weights of the RBFNNs are updated by designed adaptive laws. Besides, the center and the width values of the RBFNNs are optimized by PSO. The proposed strategy can guarantee the stability and robustness of the controlled quadrotor.
The rest of this paper is organized as follows: the dynamics model of a quadrotor is built in section 2. In Section 3, the position and attitude controllers are designed for the quadrotor based on RBFNN-SMC. PSO is conducted in section 4 to optimize the center and the width values of the RBFNNs. Simulation results are introduced in Section 5. Finally, Section 6 concludes the paper.
The physical structure of a quadrotor is presented in Figure 1. As the figure shows, there are two coordinate systems to describe the motion of the quadrotor [28], one is the body coordinate system, and the other is the inertial coordinate system. The transformation of the two coordinate systems can be realized by a rotation matrix. It depends on the three attitude angles of the quadrotor, that are the roll angle ϕ, the pitch angle θ, and the yaw angle ψ. All the attitude angles are bounded, the roll angle and the pitch angle belong to(−π/2,π/2), and the yaw angle is constrained by(−π,π).
Based on the attitude angles, the rotation matrix REB which transforms the position of the quadrotor in body coordinate system to inertial coordinate system can be expressed as (2.1).
REB=[CψCθ−CϕSψ+SϕSθCψSϕSψ+CϕSθCψCθSψCϕCψ+SθSϕSψ−SϕCψ+CϕSθSψ−SθSϕCθCϕCθ] | (2.1) |
where C=cos, S=sin.
Let x, y, z be the position variables of the center of gravity of the quadrotor along the three axes of the inertial coordinate system. Define w=[x,y,z]T, then from Newton's Second Law of Motion, one can gets that
m¨w=REB[00u1]T−[00mg]T−f | (2.2) |
where m is the mass of the quadrotor, g is the gravitational acceleration, u1 is the lifting force generated by the rotation of the propellers, and f is the air friction during the flying of the quadrotor.
Owing to external disturbances existed, (2.2) should be rewritten as
m¨w=REB[00u1]T−[00mg]T−f+dp | (2.3) |
where dp is the unknown external disturbance.
Suppose that the quadrotor is a symmetric rigid body, and let p, q, r be the angular velocity of the quadrotor's rotation about the three axes of the body coordinate system. Define ω=[p,q,r]T, then based on the Newton–Euler equation, one can obtain that
Jddt(ω)+ω×Jω=M | (2.4) |
where J=diag(Ix,Iy,Iz), is the diagonal matrix of moment of inertia, Ix,Iy,Iz denote the moment of inertia of the three axes, M is the total rotation torque. By considering the components of M, (2.4) can be rewritten as
Jddt(ω)=−ω×Jω+Mi+Mf+Mp+dr | (2.5) |
where Mi represents the input torque, which is supplied by the rotation of the four propellers. Mf represents the air friction torque, Mp is gyroscopic effect on the quadrotor, and dr denotes the unknown external disturbance.
Suppose the quadrotor is flying in small attitude angles, one has that ˙ϕ=p, ˙θ=q, ˙ψ=r and ¨ϕ=˙p, ¨θ=˙q, ¨ψ=˙r, the state equations of the quadrotor dynamics can be derived from (2.3) and (2.5) as
{¨x=u1ms(cosϕsinθcosψ+sinϕsinψ)−k1ms˙x+dx¨y=u1ms(cosϕsinθsinψ−sinϕcosψ)−k2ms˙y+dy¨z=u1mscosϕcosθ−k3ms˙z−g+dz¨ϕ=qrIy−IzIx+JrIxqωr+lIxu2−k4lIxp+dϕ¨θ=prIz−IxIy−JrIypωr+lIyu3−k5lIyq+dθ¨ψ=pqIx−IyIz+CIzu4−k6lIzr+dψ | (2.6) |
where ki (i = 1, …, 6) are the air resistance coefficients, l represents the distance of each propeller to the center of the quadrotor, u2,u3,u4 represent the input torques of roll, pitch and yaw respectively, C is the moment-force proportional coefficient, dx, dy, dz, dϕ, dθ, dψ denote the unknown disturbances to the corresponding states, Jr denotes the inertia of the propeller, ωr=ω2+ω4−ω1−ω3 is the total residual speed of the propellers, with ωi being the speed of the ith propeller, i = 1, …, 4. The relationships among ωi and ui, i = 1, …, 4, are formulated as (2.7).
[u1u2u3u4]=[bbbbb0−b00−b0b−kk−kk][ω21ω22ω23ω24] | (2.7) |
where b and k are thrust and drag coefficients, respectively.
This section introduces the design of sliding mode control with radial basis function neural networks. The control structure is shown in Figure 2.
At first, rewrite the state equation of the quadrotor's position as follows.
{¨x=uxm−k1m˙x+dx¨y=uym−k2m˙y+dy¨z=uzm−k3m˙z−g+dz | (3.1) |
with
{ux=u1(cosϕsinθcosψ+sinϕsinψ)uy=u1(cosϕsinθsinψ−sinϕcosψ)uz=u1cosϕcosθ |
From the above definition, one can see that all the control inputs ux, uy, uz are corresponding to the lifting force u1 because the quadrotor is an underactuated system. In the design showing below, the control input uz will be employed to derive the needed force u1, and ux, uy are auxiliary inputs to obtain the desired roll and pitch angles.
As SMC is employed for the control design, three sliding surfaces are defined here as (3.2) - (3.4).
s1=c1(x−xd)+(˙x−˙xd)=cex+˙ex | (3.2) |
s2=c2(y−yd)+(˙y−˙yd)=c2ey+˙ey | (3.3) |
s3=c3(z−zd)+(˙z−˙zd)=c3ez+˙ez | (3.4) |
where ci > 0 i = 1, 2, 3, are design coefficients, xd, yd, zd are the desired position coordinates of the quadrotor, ex=x−xd, ey=y−yd, ez=z−zd are the tracking errors between the actual and the desired trajectories.
According to the principle of SMC, if the control inputs are designed as follows,
ux=m(−c1˙x+c1˙xd+¨xd+k1˙xm−τ1s1−ξ1sign(s1)−dx) | (3.5) |
uy=m(−c2˙y+c2˙yd+¨yd+k2˙ym−τ2s2−ξ2sign(s2)−dy) | (3.6) |
uz=m(−c3˙z+c3˙zd+¨zd+g+k3˙zm−τ3s3−ξ3sign(s3)−dz) | (3.7) |
with τi>0 and ξi>0 being the design parameters. By the above control inputs, the derivative of si will satisfy that ˙si=−τisi−ξisign(si), i = 1, 2, 3, which implies the convergence of the tracking errors.
Since there are unknown disturbances in the designed control inputs, we introduce RBFNN to approximate the disturbances. Rewrite the expressions (3.5) - (3.7) as
ux=m(Q1+ε1−τ1s1−ξ1sign(s1)) | (3.8) |
uy=m(Q2+ε2−τ2s2−ξ2sign(s2)) | (3.9) |
uz=m(Q3+ε3−τ3s3−ξ3sign(s3)) | (3.10) |
where Qi is obtained from a RBFNN, and εi represents the approximation error which is bounded, i = 1, 2, 3. The structure of a 3 layers RBFNN is shown in Figure 3.
The three layers of the RBFNN are input layer, hidden layer and output layer [29]. The mappings from the input layer to the hidden layer are nonlinear, while the ones from the hidden layer to the output layer are linear. The inputs of the RBFNN are the desired variable D and its derivatives˙D and ¨D, and the error between actual variable and the desired one e , as well as its derivative ˙e.
Generally, Gaussian functions are selected to form the nonlinear mappings of a RBFNN, then the output of the ith node of the hidden layer can be expressed as
Φi=exp(−∥η−oi∥2σ2i) | (3.11) |
where Φi is the output of the hidden layer, η=[e,˙e,D,˙D,¨D] is the input vector, oi is the center of the ith Gaussian function, and σi is the corresponding width, i = 1, …, 5. Since the output Q is a liner function of Φi, it can be written as
Q=∑5i=1WiΦi | (3.12) |
where Wi is the weight of the RBFNN, i = 1, …, 5.
Because the weights of the RBFNNs are unknown for the approximation task, we should estimate their values online. By denoting ˆWi as the estimation of Wi, i = 1, …, 5, the estimated output of the RBFNN ˆQ can be obtained as
ˆQ=∑5i=1ˆWiΦi | (3.13) |
Employing ˆQi, and considering the robustness of SMC, the position controllers are designed as
ux=m(ˆQ1−τ1s1−ξ1sign(s1)) | (3.14) |
uy=m(ˆQ2−τ2s2−ξ2sign(s2)) | (3.15) |
uz=m(ˆQ3−τ3s3−ξ3sign(s3)) | (3.16) |
The proof of the controllers' stability, and the adaptive laws of the weights ˆWi, i = 1, …, 5, will be presented later. Based on the above controllers, the lifting force u1 and the desired roll and pitch angles are obtained as
u1=uzcosϕcosθ | (3.17) |
θd=arctan(uxcosψd+uysinψduz) | (3.18) |
ϕd=arctan(cosθd(uxsinψd−uycosψd)uz) | (3.19) |
where ϕd, θd, ψd are the desired roll, pitch and yaw angles, with ψd being given by the external order.
The purpose of attitude control is to guarantee the attitude angles converge to the desired ones. The convergence of ϕ and θ guarantees the tracking errors ex, ey move to zero quickly.
Similarly, the sliding surfaces are defined as (3.20) – (3.22)
s4=c4(ϕ−ϕd)+(˙ϕ−˙ϕd)=c4eϕ+˙eϕ | (3.20) |
s5=c5(θ−θd)+(˙θ−˙θd)=c5eθ+˙eθ | (3.21) |
s6=c6(ψ−ψd)+(˙ψ−˙ψd)=c6eψ+˙eψ | (3.22) |
where ci > 0, i = 4, 5, 6, are design coefficients, eϕ=ϕ−ϕd, eθ=θ−θd, eψ=ψ−ψd are the tracking errors between the actual and the desired angles.
The attitude control laws of the quadrotor are designed as
u2=Ixl(−c4eϕ+¨ϕd−Iy−IzIxqr+k4plIx−τ4s4−ξ4sign(s4)−JrIxqωr−dϕ) | (3.23) |
u3=Iyl(−c5eθ+¨θd−Iz−IxIypr+k5qlIy−τ5s5−ξ5sign(s5)+JrIypωr−dθ) | (3.24) |
u4=IzC(−c6eψ+¨ψd−Ix−IyIzpq+k6ψIz−τ6s6−ξ6sign(s6)−dψ) | (3.25) |
with τi>0, ξi>0 being the design parameters, i = 4, 5, 6. Based on the above control laws, the derivative of si satisfies that ˙si=−τisi−ξisign(si), i = 4, 5, 6, which implies the convergence of the tracking errors.
By employing RBFNNs to approximate the unknown disturbances in (3.23) - (3.25), and using their estimated output to construct the control laws, we can obtain the attitude control laws as
uj=m(ˆQi−τisi−ξisign(si)) | (3.26) |
with j = 2, 3, 4, i = 4, 5, 6.
In order to realize the control design, the weights of each RBFNN need to be updated. Therefore, the following adaptive law is designed.
˙ˆW=−siΦ | (3.27) |
with W=[W1W2W3W4W5]T and Φ=[Φ1Φ2Φ3Φ4Φ5]T being the weight and the Gaussian function vectors of the used RBFNN.
Assumption 3.1. The approximation error εi is bounded and satisfies that |εi|⩽ξi, i=1,⋯,6.
Theorem 3.1. With the auxiliary inputs (3.14) – (3.16), and the control laws (3.17), (3.26), and the adaptive law (3.27) for updating the weight vector of the used RBFNN, all states of the quadrotor system in (2.6) are guaranteed to converge to their desired signals, and the trajectory of the quadrotor can track the given reference.
Proof. Let ˜Qi=ˆQi−Qi(i = 1, …, 6) be the estimate error of the RBFNN's output, and ˜W=ˆW−W be the corresponding estimate error of the weight vector. Choose a Lyapunov candidate function [30] as
Vi=12si2+˜WT˜W,(i=1,⋯,6) | (3.28) |
Take the time derivative of Vi, one can get
˙Vi=si˙si+˜WT˙ˆW=si(−Qi+ˆQi−ϵi−τis−ξisign(si))+˜WT˙ˆW=˜WT(Φsi+˙ˆW)−ϵisi−τisi2−ξi|si| | (3.29) |
Taking the adaptive law (3.27) into (3.29), one can get that
˙V=−εisi−τisi2−ξi|si| | (3.30) |
According to Assumption 1, |εi|⩽ξi, so ˙V⩽0 can be guaranteed, which implies that si → 0, i = 1, …, 6. By the definition of the sliding surfaces, and the characteristics of SMC, the convergence of ex, ey, ez, eϕ, eθand eψ can be guaranteed, which means that all states of the quadrotor system converge to their desired signals, and the trajectory of the quadrotor tracks the given reference.
Based on the above control design, the stability of the quadrotor system can be guaranteed. However, the influence of the center oi and the width σi of the Gaussian function Φi, i = 1, …, 5, cannot be ignored. In this section, particle swarm optimization algorithm (PSO) will be used to adjust these parameters offline for better control performance.
PSO originates from the imitating of bird predation and has the advantages of simple implementation and fast convergence. Each bird or particle will carry the training parameters, and move according to the situations of itself and the whole group.
An evaluation function is needed for PSO, which is used to evaluate the position of the current particle. Here we choose the sum of absolute errors as the evaluation function, which is shown in (4.1).
fe=n∑i=1|μ(i)| | (4.1) |
where fe denotes the evaluation function, and μ(i) stands for the error between a sample value and the output of the corresponding RBFNN, i = 1, …, n, n is the number of training samples for PSO. The training samples are the parts of control inputs which are substituted by RBFNNs in (3.5) - (3.7) and (3.23) – (3.25) without disturbances.
Then, define the number of iterations G and the size N of the particle swarm. Each particle in the PSO contains the following information: the current position X, which represents the parameters of RBFNN that are needed to be optimized; the moving velocity V, which represents the updating rate of a particle position; as well as the particle dimension H, which is determined by the total number of the optimized parameters.
We also define the optimal value of the group as gb, and the optimal value of an individual particle as pb. At first, we initialize each pbby the value of the evaluation function at the initial position of the corresponding particle, and assign the smallest pbto gb, then update pb and gbby the following rules: for each particle, if the value of the evaluation function (4.1) is smaller than the value in last iteration, we will assign pbwith the value at the current position, otherwise pbwill be unchanged. And gbselects the smallest pbamong all the particles.
During each iteration, the position value of each particle is brought into the RBFNN to approximate the training samples, then the evaluation function can be calculated, by which pband gbcan be updated according to the rules mentioned above.
The updating values of the velocity and the position of a particle are calculated as
vi(k+1)=vi(k)+C1⋅R1⋅(pbi(k)−Xi(k))+C2⋅R2⋅(gbi(k)−Xi(k)) | (4.2) |
Xi(k+1)=Xi(k)+vi(k+1) | (4.3) |
where i = 1, …, N, C1 , C2 are the learning factors which are generally set to be 2, and R1 , R2 are random numbers belong to [0, 1].
In order to improve the global optimization ability of the PSO, an inertia factor ρ and a scale factor λ are employed for the velocity and position updating of a particle.
vi(k+1)=ρ⋅vi(k)+C1⋅R1⋅(pbi(k)−Xi(k))+C2⋅R2⋅(gbi(k)−Xi(k)) | (4.4) |
Xi(k+1)=Xi(k)+λ⋅vi(k+1) | (4.5) |
Remark: In order to maintain the integrity of the employed RBFNN, the weights of each RBFNN are also placed in X for optimizing, but only the center value o and the width value σ are taken as the optimization result, since the weight W is estimated by the adaptive law (3.27).
The parameters of our PSO are listed in Table 1. And the process of PSO is shown in Figure 4.
Variable | Quantity | Value/Range |
G | The number of iterations | 250 |
N | Population size | 50 |
H | Particle dimension | 15 |
o | Center value of RBF neural network | [-3, 3] |
σ | Width value of RBF neural network | 0.3 |
𝜌 | Inertial factor | 0.3 |
C1, C2 | learning factors | 2 |
λ | Scale factor | 0.7 |
Some simulation experiments are conducted to verify the effectiveness of the proposed control strategy, and the results of the experiments are demonstrated in this section. The parameters of the quadrotor model are given in Table 2. And the parameters of the designed sliding mode controllers are listed in Table 3. The disturbances for the simulation experiments are considered as follows, whose curves are plotted in Figures 5–6.
dx=dy=dz=0.5⋅sin(0.5t) | (5.1) |
dϕ=dθ=dψ=0.25⋅cos(πt) | (5.2) |
Variables | Value | Unit |
m | 2 | kg |
l | 0.21 | m |
Ix | 1.25 | Ns2/rad |
Iy | 1.25 | Ns2/rad |
Iz | 2.5 | Ns2/rad |
k1, k2, k3 | 0.1 | Ns/m |
k4, k5, k6 | 0.12 | Ns/m |
b | 0.5 | Ns2 |
k | 2 | N/ms2 |
C | 1 | |
Jr | 0.2 | Ns2/rad |
Variables | Value |
c1, c2, c3, c4, c5, c6 | 10 |
τ1, τ2 | 15 |
τ3 | 55 |
ξ1, ξ2, ξ3 | 0.1 |
τ4, τ5, τ6 | 10 |
ξ4, ξ5, ξ6 | 0.1 |
In order to exposit the superiority of the designed sliding mode controllers which are based on RBFNNs with PSO(SMC-RBFNN-PSO), some comparisons are made between SMC-RBFNN-PSO and sliding mode controllers based on RBFNNs without optimization (SMC-RBFNN). The center and the width values of SMC-RBFNN are determined by the experience of the designer. The comparison results are shown in Figures 7–10.
The trajectories of the controlled quadrotor with the two methods, together with the desired one are shown in Figure 7. The initial values of the position and attitude of the quadrotor are given in Table 4.
Variable | Quantity (Unit) | Value |
Xd | The desire trajectory of the X axis(m) | 2*sin (0.1*t) |
Yd | The desire trajectory of the Y axis(m) | 2*cos (0.1*t) |
Zd | The desire trajectory of the Z axis(m) | 0.1*t |
[X0, Y0, Z0] | Initial positions(m) | [0,2,0] |
ψd | The desire value of the yaw Angle(rad) | 0 |
[ϕ0, θ0, Ψ0] | Initial angles(rad) | [0,0,0] |
In order to show more details of the flight trajectories, the position and angle variables of the quadrotor are shown in Figures 8–9. It can be seen that both of the control methods can drive the quadrotor to track the desired trajectory, but SMC-RBFNN-PSO can achieve quicker convergence of all the states. This fact indicates that the center and the width values of the neural networks are effectively optimized by the PSO. The desired roll angle and pitch angle are calculated by (3.18)–(3.19), which are related to the auxiliary inputs ux,uy, so the angles ϕ and θ with the two methods are different, which can be seen in Figure 9.
Figure 10 shows the tracking errors of the three position variables with the two methods. By SMC-RBFNN, the maximum absolute errors of x, y and z are 0.5775m, 0.09m and 0.8676m, respectively. And the errors converge to zero at 6.88s, 7.24s and 6.85s, respectively. It can be seen from Figure 10 that there are unexpected fluctuations in the position tracking of the quadrotor with SMC-RBFNN. However, by SMC-RBFNN-PSO, the quadrotor can track the desired trajectory more quickly and smoothly without fluctuation
A RBFNN based SMC strategy with PSO is proposed in this paper for the tracking control of quadrotors. Based on the SMC, the position and the attitude controllers can be designed at first. However, these controllers cannot be exerted directly because of the unknown disturbances. Therefore, the RBFNNs are employed to approximate some items of the control laws. The weights of the RBFNNs are updated by adaptive mechanism. Besides, the center and the width values of the RBFNNs are optimized by PSO, with which better trajectory tracking performance can be achieved for the quadrotor. Simulation results demonstrate the stability of the system and the convergence of the states to their desired signals. Also, the comparison results show obvious superiority of the proposed SMC-RBFNN-PSO to SMC-RBFNN.
This work was supported in part by the National Natural Science Foundation of China under Grant 61603144, in part by the Natural Science Foundation of Fujian Province under Grant 2018J01095, in part by the Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University under Grant ZQN-PY509, in part by the Science and Technology Major Project Oriented to Colleges in Fujian Province for Industry Study Cooperation (2013H6016).
The authors declare there is no conflict of interest
[1] |
O'Brien J, Hayder H, Zayed Y, et al. (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 9: 402. doi: 10.3389/fendo.2018.00402
![]() |
[2] |
Cardinal-Fernández P, Ferruelo A, Esteban A, et al. (2016) Characteristics of microRNAs and their potential relevance for the diagnosis and therapy of the acute respiratory distress syndrome: from bench to bedside. Transl Res 169: 102-111. doi: 10.1016/j.trsl.2015.11.004
![]() |
[3] |
Dexheimer PJ, Cochella L (2020) MicroRNAs: from mechanism to organism. Front Cell Dev Biol 8: 409. doi: 10.3389/fcell.2020.00409
![]() |
[4] |
Nazimek K, Bryniarski K (2020) Approaches to inducing antigen-specific immune tolerance in allergy and autoimmunity: Focus on antigen-presenting cells and extracellular vesicles. Scand J Immunol 91: e12881. doi: 10.1111/sji.12881
![]() |
[5] |
Nazimek K, Bryniarski K (2020) Perspectives in manipulating EVs for therapeutic applications: focus on cancer treatment. Int J Mol Sci 21: 4623. doi: 10.3390/ijms21134623
![]() |
[6] |
Monticelli S, Ansel KM, Xiao C, et al. (2005) MicroRNA profiling of the murine hematopoietic system. Genome Biol 6: R71. doi: 10.1186/gb-2005-6-8-r71
![]() |
[7] |
Zhou B, Wang S, Mayr C, et al. (2007) miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. P Natl Acad Sci USA 104: 7080-7085. doi: 10.1073/pnas.0702409104
![]() |
[8] |
Xiao C, Calado DP, Galler G, et al. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159. doi: 10.1016/j.cell.2007.07.021
![]() |
[9] |
He Y, Jiang X, Chen J (2014) The role of miR-150 in normal and malignant hematopoiesis. Oncogene 33: 3887-3893. doi: 10.1038/onc.2013.346
![]() |
[10] |
Guduric-Fuchs J, O'Connor A, Camp B, et al. (2012) Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics 13: 357. doi: 10.1186/1471-2164-13-357
![]() |
[11] |
de Candia P, Torri A, Gorletta T, et al. (2013) Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation. PLoS One 8: e75348. doi: 10.1371/journal.pone.0075348
![]() |
[12] |
de Candia P, Torri A, Pagani M, et al. (2014) Serum microRNAs as biomarkers of human lymphocyte activation in health and disease. Front Immunol 5: 43. doi: 10.3389/fimmu.2014.00043
![]() |
[13] |
Oboshi W, Hayashi K, Takeuchi H, et al. (2020) MicroRNA-150 suppresses p27Kip1 expression and promotes cell proliferation in HeLa human cervical cancer cells. Oncol Lett 20: 210. doi: 10.3892/ol.2020.12073
![]() |
[14] |
Sur D, Burz C, Sabarimurugan S, et al. (2020) Diagnostic and prognostic significance of miR-150 in colorectal cancer: a systematic review and meta-analysis. J Pers Med 10: 99. doi: 10.3390/jpm10030099
![]() |
[15] |
Plank M, Maltby S, Mattes J, et al. (2013) Targeting translational control as a novel way to treat inflammatory disease: the emerging role of microRNAs. Clin Exp Allergy 43: 981-999. doi: 10.1111/cea.12135
![]() |
[16] |
Rebane A, Akdis CA (2014) MicroRNAs in allergy and asthma. Curr Allergy Asthma Rep 14: 424. doi: 10.1007/s11882-014-0424-x
![]() |
[17] |
Weidner J, Bartel S, Kılıç A, et al. (2020) Spotlight on microRNAs in allergy and asthma. Allergy 76: 1661-1678. doi: 10.1111/all.14646
![]() |
[18] |
Rebane A (2015) microRNA and allergy. Adv Exp Med Biol 888: 331-352. doi: 10.1007/978-3-319-22671-2_17
![]() |
[19] |
Garbacki N, Di Valentin E, Huynh-Thu VA, et al. (2011) MicroRNAs profiling in murine models of acute and chronic asthma: A relationship with mRNAs targets. PLoS One 6: e16509. doi: 10.1371/journal.pone.0016509
![]() |
[20] |
Feng MJ, Shi F, Qiu C, et al. (2012) MicroRNA-181a, -146a and -146b in spleen CD4+ T lymphocytes play proinflammatory roles in a murine model of asthma. Int Immunopharmacol 13: 347-353. doi: 10.1016/j.intimp.2012.05.001
![]() |
[21] | Badalzadeh M, Mazinani M, Pourpak Z, et al. (2019) In vitro analysis of nine microRNAs in CD8+ T cells of asthmatic patients and the effects of two FDA-approved drugs. Iran J Allergy Asthma Immunol 18: 358-368. |
[22] |
Wang JW, Li K, Hellermann G, et al. (2012) MIR-150 suppresses lung inflammation in a mouse model of experimental asthma. World Allergy Organ J 5: S9. doi: 10.1097/01.WOX.0000411771.44473.bd
![]() |
[23] |
Wang JW, Li K, Hellermann G, et al. (2011) Regulating the regulators: microRNA and asthma. World Allergy Organ J 4: 94-103. doi: 10.1186/1939-4551-4-6-94
![]() |
[24] |
Zhang XY, Tang XY, Ma LJ, et al. (2017) Schisandrin B down-regulated lncRNA BCYRN1 expression of airway smooth muscle cells by improving miR-150 expression to inhibit the proliferation and migration of ASMC in asthmatic rats. Cell Proliferat 50: e12382. doi: 10.1111/cpr.12382
![]() |
[25] |
Zhang Q, Ni W, Li Y, et al. (2020) Analysis of altered miRNA profiling in the colon of a mouse model with β-lactoglobulin allergy. Allergol Immunopathol 48: 666-674. doi: 10.1016/j.aller.2020.05.007
![]() |
[26] |
Wąsik M, Nazimek K, Nowak B, et al. (2019) Delayed-type hypersensitivity underlying casein allergy is suppressed by extracellular vesicles carrying miR-150. Nutrients 11: 907. doi: 10.3390/nu11040907
![]() |
[27] |
Ho MHK, Wong WHS, Chang C (2014) Clinical spectrum of food allergies: a comprehensive review. Clin Rev Allergy Immu 46: 225-240. doi: 10.1007/s12016-012-8339-6
![]() |
[28] |
Vennegaard MT, Bonefeld CM, Hagedorn PH, et al. (2012) Allergic contact dermatitis induces upregulation of identical microRNAs in humans and mice. Contact Dermatitis 67: 298-305. doi: 10.1111/j.1600-0536.2012.02083.x
![]() |
[29] | Wolf J, Levis WR (2012) MicroRNA 150 in humans and murine contact sensitivity. J Drugs Dermatol 11: 1152. |
[30] |
Zheng Q, Zhou L, Mi QS (2012) MicroRNA miR-150 is involved in Vα14 invariant NKT cell development and function. J Immunol 188: 2118-2126. doi: 10.4049/jimmunol.1103342
![]() |
[31] |
Goubier A, Vocanson M, Macari C, et al. (2013) Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells. J Invest Dermatol 133: 980-987. doi: 10.1038/jid.2012.404
![]() |
[32] |
Askenase PW, Bryniarski K, Paliwal V, et al. (2015) A subset of AID-dependent B-1a cells initiates hypersensitivity and pneumococcal pneumonia resistance. Ann NY Acad Sci 1362: 200-214. doi: 10.1111/nyas.12975
![]() |
[33] |
Mi QS, Xu YP, Qi RQ, et al. (2012) Lack of microRNA miR-150 reduces the capacity of epidermal Langerhans cell cross-presentation. Exp Dermatol 21: 876-877. doi: 10.1111/exd.12008
![]() |
[34] |
Gulati N, Løvendorf MB, Zibert JR, et al. (2015) Unique microRNAs appear at different times during the course of a delayed-type hypersensitivity reaction in human skin. Exp Dermatol 24: 953-957. doi: 10.1111/exd.12813
![]() |
[35] |
Ptak W, Nazimek K, Askenase PW, et al. (2015) From mysterious supernatant entity to miR-150 in antigen-specific exosomes: a history of hapten-specific T suppressor factor. Arch Immunol Ther Exp 63: 345-356. doi: 10.1007/s00005-015-0331-4
![]() |
[36] |
Bryniarski K, Ptak W, Jayakumar A, et al. (2013) Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J Allergy Clin Immun 132: 170-181. doi: 10.1016/j.jaci.2013.04.048
![]() |
[37] |
Nazimek K, Askenase PW, Bryniarski K (2018) Antibody light chains dictate the specificity of contact hypersensitivity effector cell suppression mediated by exosomes. Int J Mol Sci 19: 2656. doi: 10.3390/ijms19092656
![]() |
[38] |
Nazimek K, Bryniarski K, Ptak W, et al. (2020) Orally administered exosomes suppress mouse delayed-type hypersensitivity by delivering miR-150 to antigen-primed macrophage APC targeted by exosome-surface anti-peptide antibody light chains. Int J Mol Sci 21: 5540. doi: 10.3390/ijms21155540
![]() |
[39] |
Nazimek K, Ptak W, Nowak B, et al. (2015) Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8+ cell-derived exosomes. Immunology 146: 23-32. doi: 10.1111/imm.12466
![]() |
[40] |
Nazimek K, Bustos-Morán E, Blas-Rus N, et al. (2019) Syngeneic red blood cell-induced extracellular vesicles suppress delayed-type hypersensitivity to self-antigens in mice. Clin Exp Allergy 49: 1487-1499. doi: 10.1111/cea.13475
![]() |
[41] | Nazimek K, Nowak B, Marcinkiewicz J, et al. (2014) Enhanced generation of reactive oxygen intermediates by suppressor T cell-derived exosome-treated macrophages. Folia Med Cracov 54: 37-52. |
[42] |
Bryniarski K, Ptak W, Martin E, et al. (2015) Free extracellular miRNA functionally targets cells by transfecting exosomes from their companion cells. PLoS One 10: e0122991. doi: 10.1371/journal.pone.0122991
![]() |
[43] |
Huang XL, Zhang L, Li JP, et al. (2015) MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases. Autoimmunity 48: 503-510. doi: 10.3109/08916934.2015.1072518
![]() |
[44] |
Guan H, Peng R, Mao L, et al. (2020) Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomes. Exp Cell Res 392: 112007. doi: 10.1016/j.yexcr.2020.112007
![]() |
[45] |
Luan J, Fu J, Chen C, et al. (2019) LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration. Arthritis Res Ther 21: 276. doi: 10.1186/s13075-019-2044-2
![]() |
[46] |
Luan J, Fu J, Wang D, et al. (2020) miR-150-Based RNA interference attenuates tubulointerstitial fibrosis through the SOCS1/JAK/STAT pathway in vivo and in vitro. Mol Ther Nucleic Acids 22: 871-884. doi: 10.1016/j.omtn.2020.10.008
![]() |
[47] |
Zhou H, Hasni SA, Perez P, et al. (2013) miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol 24: 1073-1087. doi: 10.1681/ASN.2012080849
![]() |
[48] |
Du Z, Wu T, Liu L, et al. (2020) Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis. J Cell Mol Med 25: 701-715. doi: 10.1111/jcmm.16119
![]() |
[49] |
Honda N, Jinnin M, Kira-Etoh T, et al. (2013) miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3. Am J Pathol 182: 206-216. doi: 10.1016/j.ajpath.2012.09.023
![]() |
[50] |
Zidar N, Langner C, Jerala M, et al. (2020) Pathology of fibrosis in Crohn's disease-contribution to understanding its pathogenesis. Front Med 7: 167. doi: 10.3389/fmed.2020.00167
![]() |
[51] |
Ou H, Teng H, Qin Y, et al. (2020) Extracellular vesicles derived from microRNA-150-5p-overexpressing mesenchymal stem cells protect rat hearts against ischemia/reperfusion. Aging (Albany NY) 12: 12669-12683. doi: 10.18632/aging.102792
![]() |
[52] |
Yung S, Chan TM (2017) Molecular and immunological basis of tubulo-interstitial injury in lupus nephritis: a comprehensive review. Clin Rev Allergy Immu 52: 149-163. doi: 10.1007/s12016-016-8533-z
![]() |
[53] |
Okon LG, Werth VP (2013) Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Cl Rh 27: 391-404. doi: 10.1016/j.berh.2013.07.008
![]() |
[54] | Gensous N, Boizard-Moracchini A, Lazaro E, et al. (2020) Update on the cellular pathogenesis of lupus. Curr Opin Rheumatol In press. |
[55] | Chang A, Clark MR, Ko K (2020) Cellular aspects of the pathogenesis of lupus nephritis. Curr Opin Rheumatol In press. |
[56] |
Gorabi AM, Kiaie N, Aslani S, et al. (2020) Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight. J Autoimmun 114: 102529. doi: 10.1016/j.jaut.2020.102529
![]() |
[57] |
Pauley KM, Cha S (2013) RNAi therapeutics in autoimmune disease. Pharmaceuticals (Basel) 6: 287-294. doi: 10.3390/ph6030287
![]() |
[58] |
Zhang H, Huang X, Ye L, et al. (2018) B cell-related circulating microRNAs with the potential value of biomarkers in the differential diagnosis, and distinguishment between the disease activity and lupus nephritis for systemic lupus erythematosus. Front Immunol 9: 1473. doi: 10.3389/fimmu.2018.01473
![]() |
[59] |
Steen SO, Iversen LV, Carlsen AL, et al. (2015) The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus. J Rheumatol 42: 214-221. doi: 10.3899/jrheum.140502
![]() |
[60] | Nakhjavani M, Etemadi J, Pourlak T, et al. (2019) Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis. Iran J Kidney Dis 13: 198-206. |
[61] | Su YJ, Tsai NW, Kung CT, et al. (2018) Investigation of microRNA in mitochondrial apoptotic pathway in systemic lupus erythematosus. Biomed Res Int 2018: 9026357. |
[62] | Zhang M, Chen D, Zhang F, et al. (2020) Serum exosomal hsa-miR-135b-5p serves as a potential diagnostic biomarker in steroid-induced osteonecrosis of femoral head. Am J Transl Res 12: 2136-2154. |
[63] |
Méndez-Flores S, Furuzawa-Carballeda J, Hernández-Molina G, et al. (2019) MicroRNA expression in cutaneous lupus: a new window to understand its pathogenesis. Mediators Inflamm 2019: 5049245. doi: 10.1155/2019/5049245
![]() |
[64] |
Wang H, Peng W, Ouyang X, et al. (2012) Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res 160: 198-206. doi: 10.1016/j.trsl.2012.04.002
![]() |
[65] |
Carlsen AL, Schetter AJ, Nielsen CT, et al. (2013) Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 65: 1324-1334. doi: 10.1002/art.37890
![]() |
[66] |
Solé C, Moliné T, Vidal M, et al. (2019) An exosomal urinary miRNA signature for early diagnosis of renal fibrosis in lupus nephritis. Cells 8: 773. doi: 10.3390/cells8080773
![]() |
[67] |
Abulaban KM, Fall N, Nunna R, et al. (2016) Relationship of cell-free urine MicroRNA with lupus nephritis in children. Pediatric Rheumatol 14: 4. doi: 10.1186/s12969-016-0064-x
![]() |
[68] |
Omidi F, Hosseini SA, Ahmadi A, et al. (2020) Discovering the signature of a lupus-related microRNA profile in the Gene Expression Omnibus repository. Lupus 29: 1321-1335. doi: 10.1177/0961203320944473
![]() |
[69] |
Chen JQ, Papp G, Póliska S, et al. (2017) MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome. PLoS One 12: e0174585. doi: 10.1371/journal.pone.0174585
![]() |
[70] |
Ebert MS, Sharp PA (2010) MicroRNA sponges: progress and possibilities. RNA 16: 2043-2050. doi: 10.1261/rna.2414110
![]() |
[71] |
Luan J, Jiao C, Kong W, et al. (2018) circHLA-C plays an important role in lupus nephritis by sponging miR-150. Mol Ther Nucleic Acids 10: 245-253. doi: 10.1016/j.omtn.2017.12.006
![]() |
[72] |
Lu MC, Lai NS, Chen HC, et al. (2013) Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin Exp Immunol 171: 91-99. doi: 10.1111/j.1365-2249.2012.04676.x
![]() |
[73] |
Voynova EN, Skinner J, Bolland S (2015) Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus. J Immunol 194: 1503-1513. doi: 10.4049/jimmunol.1402673
![]() |
[74] |
Gao S, Yuan L, Wang Y, et al. (2017) Enhanced expression of TREM-1 in splenic cDCs in lupus prone mice and it was modulated by miR-150. Mol Immunol 81: 127-134. doi: 10.1016/j.molimm.2016.12.006
![]() |
[75] |
Fox RI (2011) Extraglandular manifestations of Sjögren's Syndrome (SS): dermatologic arthritic endocrine, pulmonary, cardiovascular, gastroenterology, renal, urology, and gynecologic manifestations. Sjögren's Syndrome New York: Springer, 285-316. doi: 10.1007/978-1-60327-957-4_17
![]() |
[76] |
Lopes AP, Hillen MR, Chouri E, et al. (2018) Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndrome. PLoS One 13: e0193157. doi: 10.1371/journal.pone.0193157
![]() |
[77] |
Ebrahimiyan H, Gharibdoost F, Aslani S, et al. (2020) microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients. Mod Rheumatol 30: 862-869. doi: 10.1080/14397595.2019.1659545
![]() |
[78] |
Heindryckx F, Binet F, Ponticos M, et al. (2016) Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing. EMBO Mol Med 8: 729-744. doi: 10.15252/emmm.201505925
![]() |
[79] |
Jinnin M (2014) Various applications of microRNAs in skin diseases. J Dermatol Sci 74: 3-8. doi: 10.1016/j.jdermsci.2014.01.004
![]() |
[80] |
Luo Y, Xiao R (2020) The epigenetic regulation of scleroderma and its clinical application. Adv Exp Med Biol 1253: 375-403. doi: 10.1007/978-981-15-3449-2_13
![]() |
[81] |
Page A, Fusil F, Cosset FL (2021) Antigen-specific tolerance approach for rheumatoid arthritis: past, present and future. Joint Bone Spine 88: 105164. doi: 10.1016/j.jbspin.2021.105164
![]() |
[82] |
Churov AV, Oleinik EK, Knip M (2015) MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. Autoimmun Rev 14: 1029-1037. doi: 10.1016/j.autrev.2015.07.005
![]() |
[83] |
Qiu M, Mo L, Li J, et al. (2020) Effects of miR-150-5p on the growth and SOCS1 expression of rheumatoid arthritis synovial fibroblasts. Clin Rheumatol 39: 909-917. doi: 10.1007/s10067-019-04894-7
![]() |
[84] |
Zhao F, Dong J, Guo J, et al. (2020) Inhibiting role of long non-coding RNA LINC01197 in inflammation in rheumatoid arthritis through the microRNA-150/THBS2 axis. Exp Cell Res 394: 112136. doi: 10.1016/j.yexcr.2020.112136
![]() |
[85] |
Niimoto T, Nakasa T, Ishikawa M, et al. (2010) MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord 11: 209. doi: 10.1186/1471-2474-11-209
![]() |
[86] |
Ebrahimiyan H, Rezaei N, Vojdanian M, et al. (2019) microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients. Int J Rheum Dis 22: 1107-1114. doi: 10.1111/1756-185X.13520
![]() |
[87] |
Rezaeepoor M, Pourjafar M, Tahamoli-Roudsari A, et al. (2020) Altered expression of microRNAs may predict therapeutic response in rheumatoid arthritis patients. Int Immunopharmacol 83: 106404. doi: 10.1016/j.intimp.2020.106404
![]() |
[88] |
Anaparti V, Smolik I, Meng X, et al. (2017) Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects. Arthritis Res Ther 19: 249. doi: 10.1186/s13075-017-1459-x
![]() |
[89] |
Chen Z, Wang H, Xia Y, et al. (2018) Therapeutic potential of mesenchymal cell-derived miR-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol 201: 2472-2482. doi: 10.4049/jimmunol.1800304
![]() |
[90] |
Elzorkany B, Mokbel A, Gamal SM, et al. (2021) Does smoking affect level of seropositivity in RA? A post-HOC global and inter-country analysis of COMORA cohort. Rheumatol Int 41: 699-705. doi: 10.1007/s00296-021-04791-w
![]() |
[91] |
Wasén C, Ospelt C, Camponeschi A, et al. (2020) Nicotine changes the microRNA profile to regulate the FOXO memory program of CD8+ T cells in rheumatoid arthritis. Front Immunol 11: 1474. doi: 10.3389/fimmu.2020.01474
![]() |
[92] |
Magrey MN, Haqqi T, Haseeb A (2016) Identification of plasma microRNA expression profile in radiographic axial spondyloarthritis-a pilot study. Clin Rheumatol 35: 1323-1327. doi: 10.1007/s10067-015-3123-7
![]() |
[93] |
Perez-Sanchez C, Font-Ugalde P, Ruiz-Limon P, et al. (2018) Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients. Hum Mol Genet 27: 875-890. doi: 10.1093/hmg/ddy008
![]() |
[94] |
Lerman G, Avivi C, Mardoukh C, et al. (2011) MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS One 6: e20916. doi: 10.1371/journal.pone.0020916
![]() |
[95] |
Li Y, Su J, Li F, et al. (2017) MiR-150 regulates human keratinocyte proliferation in hypoxic conditions through targeting HIF-1α and VEGFA: Implications for psoriasis treatment. PLoS One 12: e0175459. doi: 10.1371/journal.pone.0175459
![]() |
[96] |
Zhu WJ, Li P, Wang L, et al. (2020) Hypoxia-inducible factor-1: A potential pharmacological target to manage psoriasis. Int Immunopharmacol 86: 106689. doi: 10.1016/j.intimp.2020.106689
![]() |
[97] |
Torri A, Carpi D, Bulgheroni E, et al. (2017) Extracellular microRNA signature of human helper T cell subsets in health and autoimmunity. J Biol Chem 292: 2903-2915. doi: 10.1074/jbc.M116.769893
![]() |
[98] |
Okoye IS, Coomes SM, Pelly VS, et al. (2014) MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity 41: 89-103. doi: 10.1016/j.immuni.2014.05.019
![]() |
[99] |
Chen WX, Ren LH, Shi RH (2014) Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol 5: 63-70. doi: 10.4291/wjgp.v5.i2.63
![]() |
[100] |
Bian Z, Li L, Cui J, et al. (2011) Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol 225: 544-553. doi: 10.1002/path.2907
![]() |
[101] |
Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, et al. (2018) The administration of Escherichia coli Nissle 1917 ameliorates development of DSS-induced colitis in mice. Front Pharmacol 9: 468. doi: 10.3389/fphar.2018.00468
![]() |
[102] |
Din AU, Hassan A, Zhu Y, et al. (2020) Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism. J Nutr Biochem 79: 108353. doi: 10.1016/j.jnutbio.2020.108353
![]() |
[103] |
Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, et al. (2017) Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. Mol Nutr Food Res 61: 1700144. doi: 10.1002/mnfr.201700144
![]() |
[104] |
Morris NL, Hammer AM, Cannon AR, et al. (2017) Dysregulation of microRNA biogenesis in the small intestine after ethanol and burn injury. BBA-Mol Basis Dis 1863: 2645-2653. doi: 10.1016/j.bbadis.2017.03.025
![]() |
[105] | Wang S, Huang Y, Zhou C, et al. (2018) The role of autophagy and related microRNAs in inflammatory bowel disease. Gastroent Res Pract 2018: 7565076. |
[106] |
Ciccacci C, Politi C, Novelli G, et al. (2016) Advances in exploring the role of microRNAs in inflammatory bowel disease. MicroRNA 5: 5-11. doi: 10.2174/2211536605666160111124812
![]() |
[107] | Luo J, Wang Y, Lan D, et al. (2018) Differential expression of serum microRNAs in glucocorticoid-resistant patients with ulcerative colitis. Int J Clin Exp Pathol 11: 936-946. |
[108] |
Bao Y, Guo Y, Li Z, et al. (2014) MicroRNA profiling in Muc2 knockout mice of colitis-associated cancer model reveals epigenetic alterations during chronic colitis malignant transformation. PLoS One 9: e99132. doi: 10.1371/journal.pone.0099132
![]() |
[109] |
Zamvil SS, Hauser SL (2021) Antigen presentation by B cells in multiple sclerosis. N Engl J Med 384: 378-381. doi: 10.1056/NEJMcibr2032177
![]() |
[110] |
Hu Z, Cui Y, Qiao X, et al. (2018) Silencing miR-150 ameliorates experimental autoimmune encephalomyelitis. Front Neurosci 12: 465. doi: 10.3389/fnins.2018.00465
![]() |
[111] |
Fenoglio C, Cantoni C, Riz MD, et al. (2011) Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis. Neurosci Lett 504: 9-12. doi: 10.1016/j.neulet.2011.08.021
![]() |
[112] |
Martinelli-Boneschi F, Fenoglio C, Brambilla P, et al. (2012) MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci Lett 508: 4-8. doi: 10.1016/j.neulet.2011.11.006
![]() |
[113] |
Jernås M, Malmeström C, Axelsson M, et al. (2013) MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol 14: 32. doi: 10.1186/1471-2172-14-32
![]() |
[114] |
Bergman P, Piket E, Khademi M, et al. (2016) Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3: e219. doi: 10.1212/NXI.0000000000000219
![]() |
[115] |
Quintana E, Ortega FJ, Robles-Cedeño R, et al. (2017) miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands. Mult Scler 23: 1716-1726. doi: 10.1177/1352458516684213
![]() |
[116] |
Bruinsma IB, van Dijk M, Bridel C, et al. (2017) Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS. J Neuroinflammation 14: 235. doi: 10.1186/s12974-017-1006-3
![]() |
[117] |
Shakerian L, Ghorbani S, Talebi F, et al. (2018) MicroRNA-150 targets PU.1 and regulates macrophage differentiation and function in experimental autoimmune encephalomyelitis. J Neuroimmunol 323: 167-174. doi: 10.1016/j.jneuroim.2018.06.010
![]() |
[118] |
Dolati S, Aghebati-Maleki L, Ahmadi M, et al. (2018) Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial. J Cell Physiol 233: 5222-5230. doi: 10.1002/jcp.26301
![]() |
[119] |
Al-Ghezi ZZ, Miranda K, Nagarkatti M, et al. (2019) Combination of cannabinoids, Δ9-tetrahydrocannabinol and cannabidiol, ameliorates experimental multiple sclerosis by suppressing neuroinflammation through regulation of miRNA-mediated signaling pathways. Front Immunol 10: 1921. doi: 10.3389/fimmu.2019.01921
![]() |
[120] |
Nadin T, Haque A, Akil M, et al. (2019) Management of the idiopathic inflammatory myopathies. Prescriber 30: 28-33. doi: 10.1002/psb.1762
![]() |
[121] |
Cotton T, Niaki OZ, Zheng B, et al. (2021) Myositis in systemic lupus erythematosus. Lupus 30: 615-619. doi: 10.1177/0961203320988587
![]() |
[122] | Ye L, Zuo Y, Yang H, et al. (2019) Specific autoantibodies and clinical phenotypes correlate with the aberrant expression of immune-related microRNAs in dermatomyositis. J Immunol Res 2019: 2927061. |
[123] |
Punga T, Le Panse R, Andersson M, et al. (2014) Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker. Ann Clin Transl Neurol 1: 49-58. doi: 10.1002/acn3.24
![]() |
[124] |
Punga AR, Andersson M, Alimohammadi M, et al. (2015) Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients. J Neurol Sci 356: 90-96. doi: 10.1016/j.jns.2015.06.019
![]() |
[125] |
Molin CJ, Sabre L, Weis CA, et al. (2018) Thymectomy lowers the myasthenia gravis biomarker miR-150-5p. Neurol Neuroimmunol Neuroinflamm 5: e450. doi: 10.1212/NXI.0000000000000450
![]() |
[126] |
Westerberg E, Molin CJ, Lindblad I, et al. (2017) Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study. Muscle Nerve 56: 207-214. doi: 10.1002/mus.25493
![]() |
[127] |
Sabre L, Maddison P, Sadalage G, et al. (2018) Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis. J Neuroimmunol 321: 164-170. doi: 10.1016/j.jneuroim.2018.05.003
![]() |
[128] |
Punga AR, Punga T (2018) Circulating microRNAs as potential biomarkers in myasthenia gravis patients. Ann NY Acad Sci 1412: 33-40. doi: 10.1111/nyas.13510
![]() |
[129] |
Sabre L, Punga T, Punga AR (2020) Circulating miRNAs as potential biomarkers in myasthenia gravis: tools for personalized medicine. Front Immunol 11: 213. doi: 10.3389/fimmu.2020.00213
![]() |
[130] |
Sabre L, Maddison P, Wong SH, et al. (2019) miR-30e-5p as predictor of generalization in ocular myasthenia gravis. Ann Clin Transl Neurol 6: 243-251. doi: 10.1002/acn3.692
![]() |
[131] |
Fiorillo AA, Heier CR, Huang YF, et al. (2020) Estrogen receptor, inflammatory, and FOXO transcription factors regulate expression of myasthenia gravis-associated circulating microRNAs. Front Immunol 11: 151. doi: 10.3389/fimmu.2020.00151
![]() |
[132] |
Zhong H, Lu J, Jing S, et al. (2020) Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients. J Neuroimmunol 348: 577383. doi: 10.1016/j.jneuroim.2020.577383
![]() |
[133] |
Cron MA, Maillard S, Truffault F, et al. (2019) Causes and consequences of miR-150-5p dysregulation in myasthenia gravis. Front Immunol 10: 539. doi: 10.3389/fimmu.2019.00539
![]() |
[134] |
Cron MA, Guillochon É, Kusner L, et al. (2020) Role of miRNAs in normal and myasthenia gravis thymus. Front Immunol 11: 1074. doi: 10.3389/fimmu.2020.01074
![]() |
[135] |
Ke Q, Kroger CJ, Clark M, et al. (2020) Evolving antibody therapies for the treatment of type 1 diabetes. Front Immunol 11: 624568. doi: 10.3389/fimmu.2020.624568
![]() |
[136] |
Estrella S, Garcia-Diaz DF, Codner E, et al. (2016) Expression of miR-22 and miR-150 in type 1 diabetes mellitus: Possible relationship with autoimmunity and clinical characteristics. Med Clin-Barcelona 147: 245-247. doi: 10.1016/j.medcli.2016.05.016
![]() |
[137] |
Wang G, Gu Y, Xu N, et al. (2018) Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: Association with ongoing islet autoimmunity. Biochem Biophys Res Commun 498: 382-387. doi: 10.1016/j.bbrc.2017.06.196
![]() |
[138] |
Assmann TS, Recamonde-Mendoza M, De Souza BM, et al. (2017) MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis. Endocr Connect 6: 773-790. doi: 10.1530/EC-17-0248
![]() |
[139] |
Mazzeo A, Beltramo E, Lopatina T, et al. (2018) Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects. Exp Eye Res 176: 69-77. doi: 10.1016/j.exer.2018.07.003
![]() |
[140] |
Kim H, Bae YU, Jeon JS, et al. (2019) The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy. J Transl Med 17: 236. doi: 10.1186/s12967-019-1983-3
![]() |
[141] |
Lee WC, Li LC, Ng HY, et al. (2020) Urinary exosomal microRNA signatures in nephrotic, biopsy-proven diabetic nephropathy. J Clin Med 9: 1220. doi: 10.3390/jcm9041220
![]() |
[142] |
Mazzeo A, Lopatina T, Gai C, et al. (2019) Functional analysis of miR-21-3p, miR-30b-5p and miR-150-5p shuttled by extracellular vesicles from diabetic subjects reveals their association with diabetic retinopathy. Exp Eye Res 184: 56-63. doi: 10.1016/j.exer.2019.04.015
![]() |
[143] |
Henriques-Antunes H, Cardoso RMS, Zonari A, et al. (2019) The kinetics of small extracellular vesicle delivery impacts skin tissue regeneration. ACS Nano 13: 8694-8707. doi: 10.1021/acsnano.9b00376
![]() |
[144] |
Tian J, Pan W, Xu X, et al. (2020) NF-κB inhibits the occurrence of type 1 diabetes through microRNA-150-dependent PUMA degradation. Life Sci 255: 117724. doi: 10.1016/j.lfs.2020.117724
![]() |
[145] |
Roat R, Hossain MM, Christopherson J, et al. (2019) Circulating miR-150-5p is associated with immune-mediated early β-cell loss in a humanized mouse model. Xenotransplantation 26: e12474. doi: 10.1111/xen.12474
![]() |
[146] |
Hamada S, Masamune A, Kanno A, et al. (2015) Comprehensive analysis of serum microRNAs in autoimmune pancreatitis. Digestion 91: 263-271. doi: 10.1159/000381283
![]() |
[147] |
Wasik U, Kempinska-Podhorodecka A, Bogdanos DP, et al. (2020) Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis. Mol Med 26: 8. doi: 10.1186/s10020-019-0130-1
![]() |
[148] |
Xing L, Xu W, Qu Y, et al. (2018) miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb. Int J Hematol 107: 666-672. doi: 10.1007/s12185-018-2429-z
![]() |
[149] |
Lucherini OM, Obici L, Ferracin M, et al. (2013) First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One 8: e73443. doi: 10.1371/journal.pone.0073443
![]() |
[150] | Nazimek K, Filipczak-Bryniarska I, Bryniarski K (2015) The role of medicaments, exosomes and miRNA molecules in modulation of macrophage immune activity. Postepy Hig Med Dosw 69: 1114-1129. |
[151] |
Nazimek K, Bryniarski K (2012) The biological activity of macrophages in health and disease. Postepy Hig Med Dosw 66: 507-520. doi: 10.5604/17322693.1004080
![]() |
[152] |
Trifari S, Pipkin ME, Bandukwala HS, et al. (2013) MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation. P Natl Acad Sci USA 110: 18608-18613. doi: 10.1073/pnas.1317191110
![]() |
[153] |
Liang Y, Pan HF, Ye DQ (2015) microRNAs function in CD8+ T cell biology. J Leukocyte Biol 97: 487-497. doi: 10.1189/jlb.1RU0814-369R
![]() |
[154] |
Ma Z, Shen Y, Zeng Q, et al. (2018) MiR-150-5p regulates EGR2 to promote the development of chronic rhinosinusitis via the DC-Th axis. Int Immunopharmacol 54: 188-197. doi: 10.1016/j.intimp.2017.11.011
![]() |
[155] | Nazimek K, Bryniarski K, Santocki M, et al. (2015) Exosomes as mediators of intercellular communication: clinical implications. Pol Arch Med Wewn 125: 370-380. |
[156] |
Sang W, Sun C, Zhang C, et al. (2016) MicroRNA-150 negatively regulates the function of CD4(+) T cells through AKT3/Bim signaling pathway. Cell Immunol 306–307: 35-40. doi: 10.1016/j.cellimm.2016.05.007
![]() |
[157] |
Sang W, Wang Y, Zhang C, et al. (2016) MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway. Immunol Lett 172: 1-10. doi: 10.1016/j.imlet.2015.11.001
![]() |
[158] |
Tung SL, Boardman DA, Sen M, et al. (2018) Regulatory T cell-derived extracellular vesicles modify dendritic cell function. Sci Rep 8: 6065. doi: 10.1038/s41598-018-24531-8
![]() |
[159] |
Neamah WH, Singh NP, Alghetaa H, et al. (2019) AhR activation leads to massive mobilization of myeloid-derived suppressor cells with immunosuppressive activity through regulation of CXCR2 and microRNA miR-150-5p and miR-543-3p that target anti-inflammatory genes. J Immunol 203: 1830-1844. doi: 10.4049/jimmunol.1900291
![]() |
[160] |
Warth SC, Hoefig KP, Hiekel A, et al. (2015) Induced miR-99a expression represses Mtor cooperatively with miR-150 to promote regulatory T-cell differentiation. EMBO J 34: 1195-1213. doi: 10.15252/embj.201489589
![]() |
[161] |
Kluiver JL, Chen C-Z (2012) MicroRNAs regulate B-cell receptor signaling-induced apoptosis. Genes Immun 13: 239-244. doi: 10.1038/gene.2012.1
![]() |
[162] |
Mraz M, Chen L, Rassenti LZ, et al. (2014) miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood 124: 84-95. doi: 10.1182/blood-2013-09-527234
![]() |
[163] |
Cerna K, Oppelt J, Chochola V, et al. (2019) MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells. Leukemia 33: 403-414. doi: 10.1038/s41375-018-0230-x
![]() |
[164] |
Musilova K, Devan J, Cerna K, et al. (2018) miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels. Blood 132: 2389-2400. doi: 10.1182/blood-2018-06-855502
![]() |
[165] |
Jiang XX, Liu Y, Li H, et al. (2016) MYSM1/miR-150/FLT3 inhibits B1a cell proliferation. Oncotarget 7: 68086-68096. doi: 10.18632/oncotarget.11738
![]() |
[166] |
Ma Y, Liu Y, Hou H, et al. (2018) MiR-150 predicts survival in patients with sepsis and inhibits LPS-induced inflammatory factors and apoptosis by targeting NF-κB1 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 500: 828-837. doi: 10.1016/j.bbrc.2018.04.168
![]() |
[167] |
Palagani A, Op de Beeck K, Naulaerts S, et al. (2014) Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells. PLoS One 9: e113842. doi: 10.1371/journal.pone.0113842
![]() |
[168] |
Nazimek K, Bustos-Morán E, Blas-Rus N, et al. (2021) Antibodies enhance the suppressive activity of extracellular vesicles in mouse delayed-type hypersensitivity. Pharmaceuticals 14: 734. doi: 10.3390/ph14080734
![]() |
1. | Zhiye Zhao, Xiaozheng Jin, Adaptive neural network-based sliding mode tracking control for agricultural quadrotor with variable payload, 2022, 103, 00457906, 108336, 10.1016/j.compeleceng.2022.108336 | |
2. | Gaowang Zhang, Feng Wang, Jian Chen, Huayi Li, Fixed-time sliding mode attitude control of a flexible spacecraft with rotating appendages connected by magnetic bearing, 2022, 19, 1551-0018, 2286, 10.3934/mbe.2022106 | |
3. | Shurui Huang, Yueneng Yang, Adaptive Neural-Network-Based Nonsingular Fast Terminal Sliding Mode Control for a Quadrotor with Dynamic Uncertainty, 2022, 6, 2504-446X, 206, 10.3390/drones6080206 | |
4. | Yutao Jing, Xianghe Wang, Juan Heredia-Juesas, Charles Fortner, Christopher Giacomo, Rifat Sipahi, Jose Martinez-Lorenzo, PX4 Simulation Results of a Quadcopter with a Disturbance-Observer-Based and PSO-Optimized Sliding Mode Surface Controller, 2022, 6, 2504-446X, 261, 10.3390/drones6090261 | |
5. | Yunxia Wei, Yuanfei Zhang, Bin Hang, Construction and management of smart campus: Anti-disturbance control of flexible manipulator based on PDE modeling, 2023, 20, 1551-0018, 14327, 10.3934/mbe.2023641 | |
6. | Hyeongki Ahn, Mingyuan Hu, Yoonuh Chung, Kwanho You, Sliding-Mode Control for Flight Stability of Quadrotor Drone Using Adaptive Super-Twisting Reaching Law, 2023, 7, 2504-446X, 522, 10.3390/drones7080522 | |
7. | Delima Palwa Sari, Purwadi Agus Darwito, A. Saregar, R. Umam, A. Rahmat, Control System for Quadcopter UAV based SMC-RBFNN with External Disturbance, 2024, 482, 2267-1242, 03004, 10.1051/e3sconf/202448203004 | |
8. | Benshan Liu, Yongsheng Gao, Liang Gao, Junming Zhang, Yanhe Zhu, Jie Zhao, Research on the control of thrust vectoring turbojet aircraft with uncertainties and input saturation based on fixed‐time control, 2024, 34, 1049-8923, 11282, 10.1002/rnc.7571 | |
9. | Abdul Kareem, Ganesh Aithal, 2024, Chapter 15, 978-981-99-4443-9, 205, 10.1007/978-981-99-4444-6_15 | |
10. | Hyunchang Kim, Hyeongki Ahn, Yoonuh Chung, Kwanho You, Quadrotor Position and Attitude Tracking Using Advanced Second-Order Sliding Mode Control for Disturbance, 2023, 11, 2227-7390, 4786, 10.3390/math11234786 | |
11. | Dawit Kefale Wassie, Lebsework Negash Lemma, Abrham Tadesse Kassie, HGAPSO-Based Third Order-SMC, ST-SMC, and SMC Strategy for AAV Control: A Comparative Analysis, 2025, 13, 2169-3536, 52821, 10.1109/ACCESS.2025.3553146 |
Variable | Quantity | Value/Range |
G | The number of iterations | 250 |
N | Population size | 50 |
H | Particle dimension | 15 |
o | Center value of RBF neural network | [-3, 3] |
σ | Width value of RBF neural network | 0.3 |
𝜌 | Inertial factor | 0.3 |
C1, C2 | learning factors | 2 |
λ | Scale factor | 0.7 |
Variables | Value | Unit |
m | 2 | kg |
l | 0.21 | m |
Ix | 1.25 | Ns2/rad |
Iy | 1.25 | Ns2/rad |
Iz | 2.5 | Ns2/rad |
k1, k2, k3 | 0.1 | Ns/m |
k4, k5, k6 | 0.12 | Ns/m |
b | 0.5 | Ns2 |
k | 2 | N/ms2 |
C | 1 | |
Jr | 0.2 | Ns2/rad |
Variables | Value |
c1, c2, c3, c4, c5, c6 | 10 |
τ1, τ2 | 15 |
τ3 | 55 |
ξ1, ξ2, ξ3 | 0.1 |
τ4, τ5, τ6 | 10 |
ξ4, ξ5, ξ6 | 0.1 |
Variable | Quantity (Unit) | Value |
Xd | The desire trajectory of the X axis(m) | 2*sin (0.1*t) |
Yd | The desire trajectory of the Y axis(m) | 2*cos (0.1*t) |
Zd | The desire trajectory of the Z axis(m) | 0.1*t |
[X0, Y0, Z0] | Initial positions(m) | [0,2,0] |
ψd | The desire value of the yaw Angle(rad) | 0 |
[ϕ0, θ0, Ψ0] | Initial angles(rad) | [0,0,0] |
Variable | Quantity | Value/Range |
G | The number of iterations | 250 |
N | Population size | 50 |
H | Particle dimension | 15 |
o | Center value of RBF neural network | [-3, 3] |
σ | Width value of RBF neural network | 0.3 |
𝜌 | Inertial factor | 0.3 |
C1, C2 | learning factors | 2 |
λ | Scale factor | 0.7 |
Variables | Value | Unit |
m | 2 | kg |
l | 0.21 | m |
Ix | 1.25 | Ns2/rad |
Iy | 1.25 | Ns2/rad |
Iz | 2.5 | Ns2/rad |
k1, k2, k3 | 0.1 | Ns/m |
k4, k5, k6 | 0.12 | Ns/m |
b | 0.5 | Ns2 |
k | 2 | N/ms2 |
C | 1 | |
Jr | 0.2 | Ns2/rad |
Variables | Value |
c1, c2, c3, c4, c5, c6 | 10 |
τ1, τ2 | 15 |
τ3 | 55 |
ξ1, ξ2, ξ3 | 0.1 |
τ4, τ5, τ6 | 10 |
ξ4, ξ5, ξ6 | 0.1 |
Variable | Quantity (Unit) | Value |
Xd | The desire trajectory of the X axis(m) | 2*sin (0.1*t) |
Yd | The desire trajectory of the Y axis(m) | 2*cos (0.1*t) |
Zd | The desire trajectory of the Z axis(m) | 0.1*t |
[X0, Y0, Z0] | Initial positions(m) | [0,2,0] |
ψd | The desire value of the yaw Angle(rad) | 0 |
[ϕ0, θ0, Ψ0] | Initial angles(rad) | [0,0,0] |